Netherlands· NL-769b2c4a5b15

Valaciclovir 1000 mg Focus, filmomhulde tabletten

A valaciclovir product containing valaciclovirhydrochloride x-water, registered in Netherlands by Focus Care Pharmaceuticals B.V.. The same ATC class is registered in 18 of our 19 countries.

ATC J05AB11

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about valaciclovirhydrochloride x-waterAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Valaciclovir is registered in 18 of 19 countries.

Countries holding a registration under ATC J05AB11 (valaciclovir), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
11 of them publish a price we can compare per daily dose

Search valaciclovir products by name

Valaciclovir · ATC J05AB11

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of valaciclovir costs, country by country.

Normalised to the WHO defined daily dose (3 g), the median price runs from $4.81 in France to $31.05 in United States — a ×6.5 gap.

5 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Valaciclovir · price per daily dose (3 g)

USD · FX 28 Sept 2026

US United States$31.05 (acquisition cost)
CH Switzerland$12.40
IT Italy$9.73
ES Spain$7.89
FR France$4.81

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: VALACICLOVIRHYDROCHLORIDE X-WATER
Manufacturer: Focus Care Pharmaceuticals B.V.
Country: Netherlands (NL)
ATC code: J05AB11
ATC class: Valaciclovir
Defined daily dose: 3 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
125516

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

226 interactions on record for valaciclovir.

Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check valaciclovir against other medicines How interaction checks work

Valaciclovir · interactions on record

226 records

16 severe
29 moderate
2 minor
178 info

Most severe, free to view

TemsirolimusL01EG01severe
EverolimusL01EG02severe
SirolimusL01EG04severe
TemsirolimusL01XE09severe

1 more interaction with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Valaciclovir in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All valaciclovir products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

Austria · Valaciclovir Actavis, Valaciclovir Allen
Belgium · Valaciclovir Ab, Valaciclovir Sandoz
Bulgaria · Валтрекс
Cyprus · Valtrex
Czechia · Valaciclovir +pharma, Valacilovir Viatris
Germany · Valaciclovir 1 A Pharma, Valaciclovir Aurobindo
Denmark · Valaciclovir "sandoz", Valaciclovir 1a Farma
Estonia · Valaciclovir Actavis, Valtrex
Spain · Tridiavir, Valaciclovir Almus
Finland · Flushnil, Valaciclovir Ratiopharm
France · Valaciclovir Almus, Valaciclovir Arrow
United Kingdom (Northern Ireland) · Valaciclovir Accord Healthcare, Valaciclovir Aristo
Greece · Valomed, Valtrex
Ireland · Valaciclovir Accord Healthcare Ireland, Valaciclovir Bluefish
Iceland · Valablis Forte, Valablis Normal
Italy · Talavir, Valaciclovir Aurobindo
Lithuania · Valaciclovir Actavis, Valtrex
Luxembourg · Zelitrex
Latvia · Valaciclovir Actavis, Valtrex
Norway · Valaciclovir Sandoz, Valaciclovir Viatris
Poland · Vaciclor
Portugal · Valaciclovir Arpedex, Valaciclovir Aurobindo
Romania · Valaciclovir Arena, Valtrex
Sweden · Valaciclovir Actavis, Valaciclovir Bluefish
Slovenia · Valtrex
Slovakia · Valtrex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/5663b788-282e-4425-ad8b-dfd15dfb748d
GET /v1/drugs/5663b788-282e-4425-ad8b-dfd15dfb748d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h125516_smpc.pdf",
  "strength": null,
  "atc_label": "Valaciclovir",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg125516",
  "excipients": [
    "CROSPOVIDON (E 1202)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "MACROGOL 400",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL, GEPREGELATINEERD",
    "POLYSORBAAT 80 (E 433)",
    "POVIDON K 90 (E 1201)",
    "SILICIUMDIOXIDE (E 551)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "VALACICLOVIRHYDROCHLORIDE X-WATER"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h125516.pdf",
  "authorised_at": "2021/03/15",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "125516",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about valaciclovir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console